↓ Skip to main content

Cochrane Database of Systematic Reviews

Olanzapine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs
1 blog
twitter
15 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
217 Mendeley
Title
Olanzapine for schizophrenia
Published in
Cochrane database of systematic reviews, April 2005
DOI 10.1002/14651858.cd001359.pub2
Pubmed ID
Authors

Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El-Dosoky, Saroja Indran

Abstract

Olanzapine is an atypical antipsychotic reported to be effective without producing disabling extrapyramidal adverse effects associated with older, typical antipsychotic drugs.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Sweden 1 <1%
United Kingdom 1 <1%
Singapore 1 <1%
United States 1 <1%
Unknown 212 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 19%
Researcher 37 17%
Student > Bachelor 19 9%
Student > Doctoral Student 15 7%
Student > Ph. D. Student 15 7%
Other 50 23%
Unknown 39 18%
Readers by discipline Count As %
Medicine and Dentistry 78 36%
Psychology 30 14%
Nursing and Health Professions 14 6%
Pharmacology, Toxicology and Pharmaceutical Science 14 6%
Social Sciences 9 4%
Other 25 12%
Unknown 47 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2020.
All research outputs
#1,058,948
of 18,771,444 outputs
Outputs from Cochrane database of systematic reviews
#2,653
of 11,857 outputs
Outputs of similar age
#10,179
of 168,035 outputs
Outputs of similar age from Cochrane database of systematic reviews
#26
of 152 outputs
Altmetric has tracked 18,771,444 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,857 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.4. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,035 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.